Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Malvern Instruments Publishes New White Paper to Coincide with PepTalk 2014

Published: Wednesday, January 08, 2014
Last Updated: Tuesday, January 07, 2014
Bookmark and Share
Company publishes new white paper on ‘Developing a bioformulation stability profile’.

Malvern Instruments’ range of analytical solutions for the biopharmaceuticals industry focuses specifically on critical testing pathways and manufacturing requirements.

As well as exhibiting solutions from its growing analytical toolbox at PepTalk 2014 (January 13-17, 2014; Palm Springs, CA), Malvern will publish a new white paper that discusses the combined use of light scattering and microcapillary viscometry in the development of a bioformulation stability profile.

Copies will be available on Malvern’s Booth #315 at PepTalk 2014 and will be downloadable from the Malvern website after the event.

This new publication, ‘Developing a bioformulation stability profile’ is issued through Malvern’s Bioscience Development Initiative, which has been established to accelerate the innovation, development and promotion of novel technologies, products and capabilities to address unmet measurement needs in the bioscience arena.

Malvern’s analytical toolbox for biopharmaceutical development provides tried and trusted solutions as well as new technologies.

Established systems include Viscotek size exclusion chromatographs for assessing product purity and the Zetasizer range for sizing and zeta potential analysis for product stability.

New to the Malvern range are the Viscosizer 200, designed to assess bioformulation suitability and stability at points at the very beginning of development, together with Archimedes, Morphologi and the NanoSight ranges of instruments to quantify early aggregation and improve subvisible particle detection and identification in bioformulations.

Visit the Malvern booth #315 at PepTalk to collect a copy of ‘‘Developing a bioformulation stability profile’ or visit the Malvern website for further details of Malvern’s biopharmaceuticals portfolio.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Malvern Signs Exclusive Agreement with Affinity Biosensors
Agreement to distribute Affinity Biosensors’ Archimedes system extends Malvern Instruments’ biopharma solutions.
Tuesday, March 05, 2013
Malvern Specialist Discusses Light Scattering Techniques at BioProcess International Europe 2011
Dr Hanna Jankevics will present a poster at the 7th annual BioProcess International Europe conference in Nice (France).
Thursday, April 14, 2011
Malvern Specialist Tests Sensitivity Limits of Dynamic Light Scattering
Malvern’s Zetasizer Nano systems use light scattering techniques to measure the hydrodynamic size, zeta potential and molecular weight of proteins and nanoparticles.
Wednesday, October 06, 2010
Scientific News
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Turning up the Tap on Microbes Leads to Better Protein Patenting
Mining millions of proteins could become faster and easier with a new technique that may also transform the enzyme-catalyst industry, according to University of California, Davis, researchers.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Novel Proteins Linked to Huntington's Disease
University of Florida Health researchers have made a new discovery about Huntington's disease, showing that the gene that causes the fatal disorder makes an unexpected "cocktail" of mutant proteins that accumulate in the brain.
Enzyme Critical to Maintaining Telomere Length Discovered
New method expected to speed understanding of short telomere diseases and cancer.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos